亚临床库欣研究进展
Progress in Subclinical Cushing’s Syndrome
摘要: 亚临床库欣综合征是指皮质醇自主分泌轻度增高而无典型库欣综合征临床表现、可以导致多种代谢异常的一种疾病,在临床上较库欣综合征常见;亚临床库欣综合征多见于肾上腺意外瘤的患者。随着当前医学研究、影像学技术的不断进展,亚临床库欣综合征的检出率在不断增加。亚临床库欣综合征可以造成葡萄糖代谢障碍、血脂异常、高血压、骨脆性增高、亚临床动脉粥样硬化、内脏脂肪堆积、感染风险高、肌肉损伤、情绪障碍和高凝状态等,但因无典型临床症状且起病隐匿、病程进展缓慢,在临床工作中容易被忽视。本文就近年来亚临床库欣综合征的研究进展做一综述。
Abstract: Subclinical Cushing’s Syndrome refers to a mild increase in autonomous secretion of cortisol with-out the clinical manifestations of typical Cushing’s syndrome, and can lead to a variety of metabolic abnormalities, which is more common than Cushing’s syndrome; subclinical Cushing’s syndrome is most commonly seen in patients with adrenal adenomas. The detection rate of Subclinical Cushing’s Syndrome is increasing with the current advances in medical research and imaging technology. Subclinical Cushing’s Syndrome can cause impaired glucose metabolism, dyslipidemia, hyperten-sion, increased bone fragility, subclinical atherosclerosis, accumulation of visceral fat, high risk of infection, muscle damage, mood disorders and hypercoagulability, etc. However, it is easy to be ne-glected in clinical work because of the absence of typical clinical symptoms, insidious onset, and slow progression of the disease. In this article, we review the research progress of Subclinical Cush-ing’s Syndrome in recent years.
文章引用:赵陆蕊, 张瑞霞. 亚临床库欣研究进展[J]. 临床医学进展, 2023, 13(12): 18991-18997. https://doi.org/10.12677/ACM.2023.13122671

参考文献

[1] Beierwaltes, W.H., Sturman, M.F., Ryo, U., et al. (1974) Imaging Functional Nodules of the Adrenal Glands with 131-I-19-Iodocholesterol. Journal of Nuclear Medicine, 15, 246-251.
[2] 李乐乐, 窦京涛. 如何从肾上腺意外瘤中甄选出亚临床库欣综合征[J]. 中国实用内科杂志, 2017, 37(10): 867-870. [Google Scholar] [CrossRef
[3] 白求恩精神研究会内分泌和糖尿病学分会《2022年亚临床库欣综合征专家指导建议》编写组. 2022年亚临床库欣综合征专家指导建议[J]. 国际内分泌代谢杂志, 2023, 43(1): 69-76. [Google Scholar] [CrossRef
[4] Terzolo, M., Bovio, S., Pia, A., et al. (2007) Sub-clinical Cushing’s Syndrome. Arquivos Brasileiros de Endocrinologia e Metabologia, 51, 1272-1279. [Google Scholar] [CrossRef
[5] Favero, V., Cremaschi, A., Parazzoli, C., et al. (2022) Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside. International Journal of Molecular Sciences, 23, Article No. 673. [Google Scholar] [CrossRef] [PubMed]
[6] 赵乃蕊, 袁戈恒, 张俊清. 488例肾上腺意外瘤住院患者临床特征及诊疗[J]. 重庆医科大学学报, 2022, 47(6): 652-656.
[7] Jing, Y., Hu, J., Luo, R., et al. (2022) Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population: A Cross-Sectional Study. An-nals of Internal Medicine, 175, 1383-1391. [Google Scholar] [CrossRef
[8] Geelhoed, G.W. and Druy, E.M. (1982) Management of the Adrenal “Incidentaloma”. Surgery, 92, 866-874.
[9] Ioachimescu, A.G., Remer, E.M. and Hamrahian, A.H. (2015) Adrenal Incidentalomas: A Disease of Modern Technology Offering Opportunities for Im-proved Patient Care. Endocrinology and Metabolism Clinics of North America, 44, 335-354. [Google Scholar] [CrossRef] [PubMed]
[10] Zografos, G.N., Perysinakis, I. and Vassilatou, E. (2014) Subclinical Cushing’s Syndrome: Current Concepts and Trends. Hormones (Athens), 13, 323-337. [Google Scholar] [CrossRef] [PubMed]
[11] Steffensen, C., Bak, A.M., Rubeck, K.Z., et al. (2010) Epidemiolo-gy of Cushing’s Syndrome. Neuroendocrinology, 92, 1-5. [Google Scholar] [CrossRef] [PubMed]
[12] 杨菁. 亚临床和肾上腺腺瘤型库欣综合征的临床特点和病理生理机制研究[D]: [硕士学位论文]. 杭州: 浙江大学, 2019.[CrossRef
[13] 何新尧, 陈晓, 施秀华, 等. 垂体性库欣病手术疗效分析[J]. 中华神经外科疾病研究杂志, 2013, 12(6): 535-539.
[14] Nawata, H., Demura, H., Suda, T. and Takayanagi, R. (1996) Adrenal Preclinical Cushing’s Syndrome. Annual Report of the Ministry of Health and Welfare “Disorder of Ad-renal Hormones” Research Committee, Japan 1995, 223-226. (In Japanese)
[15] Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., et al. (2011) AME Position Statement on Adrenal Incidentaloma. European Journal of Endocrinology, 164, 851-870. [Google Scholar] [CrossRef
[16] Yanase, T., Oki, Y., Katabami, T., Otsuki, M., Kageyama, K., Tanaka, T., et al. (2018) New Diagnostic Criteria of Adrenal Subclinical Cushing’s Syndrome: Opin-ion from the Japan Endocrine Society. Endocrine Journal, 65, 383-393. [Google Scholar] [CrossRef
[17] Tateishi, Y., Kouyama, R., Mihara, M., Doi, M., Yoshimoto, T., et al. (2012) Evaluation of Salivary Cortisol Measurements for the Diagnosis of Subclinical Cushing’s Syndrome. Endo-crine Journal, 59, 283-289. [Google Scholar] [CrossRef
[18] Shen, J., Sun, M., Zhou, B. and Yan, J.P. (2014) Nonconformity in the Clinical Practice Guidelines for Subclinical Cushing’s Syndrome: Which Guidelines Are Trustworthy? European Journal of Endocrinology, 171, 421-431. [Google Scholar] [CrossRef
[19] Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., et al. (2016) Management of Adrenal Incidentalomas: European Society of Endocrinology Clinical Practice Guideline in Col-laboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 175, G1-G34. [Google Scholar] [CrossRef
[20] Rossi, R., Tauchmanova, L., Luciano, A., Di Martino, M., Bat-tista, C., Del Viscovo, L., Nuzzo, V. and Lombardi, G. (2000) Subclinical Cushing’s Syndrome in Patients with Adrenal Incidentaloma: Clinical and Biochemical Features. The Journal of Clinical Endocrinology & Metabolism, 85, 1440-1448. [Google Scholar] [CrossRef] [PubMed]
[21] Vassilatou, E., Vryonidou, A., Michalopoulou, S., Manolis, J., Carat-zas, J., Phenekos, C. and Tzavara, I. (2009) Hormonal Activity of Adrenal Incidentalomas: Results from a Long-Term Follow-Up Study. Clinical Endocrinology (Oxford), 70, 674-679. [Google Scholar] [CrossRef] [PubMed]
[22] Martins, L.C., Conceicao, F.L., Muxfeldt, E.S., et al. (2012) Prevalence and Associated Factors of Subclinical Hypercortisolism in Patients with Resistant Hypertension. Journal of Hypertension, 30, 967-973. [Google Scholar] [CrossRef
[23] Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G. and Angeli, A. (2005) Subclinical Cushing’s Syndrome in Adrenal Incidentalomas. Endocrinology and Me-tabolism Clinics of North America, 34, 423-439. [Google Scholar] [CrossRef] [PubMed]
[24] Reincke, M., Fassnacht, M., Väth, S., Mora, P. and Allolio, B. (1996) Adrenal Incidentalomas: A Manifestation of the Metabolic Syndrome? Endocrine Research, 22, 757-761. [Google Scholar] [CrossRef] [PubMed]
[25] Fernández-Real, J.M., Engel, W.R., Simó, R., Salinas, I. and Webb, S.M. (1998) Study of Glucose Tolerance in Consecutive Patients Harbouring Incidental Adrenal Tumours. Study Group of Incidental Adrenal Adenoma. Clinical Endocrinology (Oxford), 49, 53-61. [Google Scholar] [CrossRef] [PubMed]
[26] Terzolo, M., Bovio, S., Pia, A., Conton, P.A., Reimondo, G., Dall’Asta, C., Bemporad, D., Angeli, A., Opocher, G., Mannelli, M., Ambrosi, B. and Mantero, F. (2005) Midnight Serum Cortisol as a Marker of Increased Cardiovascular Risk in Patients with a Clinically in Apparent Adrenal Adenoma. European Journal of Endocrinology, 153, 307-315. [Google Scholar] [CrossRef] [PubMed]
[27] Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.A., Fazio, S. and Lombardi, G. (2002) Patients with Subclinical Cushing’s Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk. The Journal of Clinical Endocrinology & Metabolism, 87, 4872-4878. [Google Scholar] [CrossRef] [PubMed]
[28] Giordano, R., Marinazzo, E., Berardelli, R., Picu, A., Maccario, M., Ghigo, E. and Arvat, E. (2010) Long-Term Morphological, Hormonal, and Clinical Follow-Up in a Single Unit on 118 Patients with Adrenal Incidentalomas. European Journal of Endocrinology, 162, 779-785. [Google Scholar] [CrossRef
[29] Pivonello, R., De Martino, M.C., De Leo, M., Tauchmanovà, L., Fag-giano, A., Lombardi, G. and Colao, A. (2007) Cushing’s Syndrome: Aftermath of the Cure. Arquivos Brasileiros de Endocrinologia e Metabologia, 51, 1381-1391. [Google Scholar] [CrossRef
[30] Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R. and Stewart, P.M. (2020) Adrenal Incidentaloma. Endocrine Reviews, 41, 775-820. [Google Scholar] [CrossRef] [PubMed]
[31] Ceccato, F., Trementino, L., Barbot, M., Antonelli, G., Plebani, M., Denaro, L., Regazzo, D., Rea, F., et al. (2017) Diagnostic Accuracy of Increased Urinary Cortisol/Cortisone Ratio to Differentiate ACTH-Dependent Cushing’s Syndrome. Clinical Endocrinology (Oxford), 87, 500-507. [Google Scholar] [CrossRef] [PubMed]
[32] Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E. and Arvat, E. (2012) Glucose Metabolism in Patients with Subclinical Cushing’s Syndrome. Endocrine, 41, 415-423. [Google Scholar] [CrossRef] [PubMed]
[33] Di Dalmazi, G., Fanelli, F., Mezzullo, M., Casadio, E., Rinaldi, E., Garelli, S., Giampalma, E., Mosconi, C., Golfieri, R., Vicennati, V., Pagotto, U. and Pasquali, R. (2015) Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas. The Journal of Clinical Endocrinology & Metabolism, 100, 3529-3538. [Google Scholar] [CrossRef
[34] Toniato, A., Merante-Boschin, I., Opocher, G., Pelizzo, M.R., Schiavi, F. and Ballotta, E. (2009) Surgical versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Inci-dentalomas: A Prospective Randomized Study. Annals of Surgery, 249, 388-391. [Google Scholar] [CrossRef
[35] Morelli, V., Eller-Vainicher, C., Salcuni, A.S., Coletti, F., Iorio, L., Muscogiuri, G., Della Casa, S., Arosio, M., Ambrosi, B., Beck-Peccoz, P. and Chiodini, I. (2011) Risk of New Vertebral Fractures in Patients with Adrenal Incidentaloma with and without Subclinical Hypercortisolism: A Multicenter Longitudinal Study. Journal of Bone and Mineral Research, 26, 1816-1821. [Google Scholar] [CrossRef] [PubMed]
[36] Chiodini, I., Vainicher, C.E., Morelli, V., Palmieri, S., Cairoli, E., Salcuni, A.S., Copetti, M. and Scillitani, A. (2016) Mechanisms in Endocrinology: Endogenous Subclinical Hypercortisolism and Bone: A Clinical Review. European Journal of Endocrinology, 175, R265-R282. [Google Scholar] [CrossRef
[37] Chiodini, I., Morelli, V., Masserini, B., Salcuni, A.S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., Iorio, L., Beck-Peccoz, P., Arosio, M., Ambrosi, B. and Scillitani, A. (2009) Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 94, 3207-3214. [Google Scholar] [CrossRef] [PubMed]
[38] Swiatkowska-Stodulska, R., Kaniuka-Jakubowska, S., Wisniewski, P., et al. (2011) The Estimation of Selected Endogenous Anticoagulation Sys-tem Parameters in Patients with Subclinical Cushing’s Syndrome. European Journal of Endocrinology, 165, 865-871. [Google Scholar] [CrossRef
[39] Swiatkowska-Stodulska, R., Skibowska-Bielinska, A., Wisniewski, P., et al. (2015) Activity of Selected Coagulation Factors in Overt and Subclinical Hypercortisolism. Endocrine Journal, 62, 687-694. [Google Scholar] [CrossRef
[40] Swiatkowska-Stodulska, R., Kaniuka-Jakubowska, S., Wisniewski, P., et al. (2012) Homocysteine and alpha-1 Antitrypsin Concentration in Patients with Subclinical Hypercortisolemia. Advances in Medical Sciences, 57, 302-307. [Google Scholar] [CrossRef] [PubMed]
[41] Rosario Pivonello, A.M.I., De Martino, M.C., Newell-Price, J., Biller, B.M.K. and Colao, A. (2016) Complications of Cushing’s Syndrome: State of the Art. The Lancet Diabetes & Endocrinology, 4, 611-629. [Google Scholar] [CrossRef
[42] Lado-Abeal, J., Rodriguez-Arnao, J., Newell-Price, J.D., et al. (1998) Menstrual Abnormalities in Women with Cushing’s Disease Are Correlated with Hypercortisolemia Rather than Raised Circulating Androgen Levels. The Journal of Clinical Endocrinology & Metabolism, 83, 3083-3088. [Google Scholar] [CrossRef] [PubMed]
[43] Lause, M., Kamboj, A. and Fernandez Faith, E. (2017) Dermatologic Manifestations of Endocrine Disorders. Translational Pediatrics, 6, 300-312. [Google Scholar] [CrossRef] [PubMed]
[44] Luton, J.P., Thieblot, P., Valcke, J.C., et al. (1977) Reversible Gonad-otropin Deficiency in Male Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism, 45, 488-495. [Google Scholar] [CrossRef] [PubMed]
[45] Wedrychowicz, A., Hull, B., Tyrawa, K., et al. (2019) Cushing Disease in Children and Adolescents-Assessment of the Clinical Course, Diagnostic Process, and Effects of the Treat-ment-Experience from a Single Paediatric Centre. Pediatric Endocrinology, Diabetes, and Metabolism, 25, 127-143. [Google Scholar] [CrossRef] [PubMed]
[46] Palmieri, S., Morelli, V., Salcuni, A.S., et al. (2014) GH Secretion Reserve in Subclinical Hypercortisolism. Pituitary, 17, 470-476. [Google Scholar] [CrossRef] [PubMed]
[47] Fredrickson, D.S., Forsham, P.H. and Thorn, G.W. (1952) The Effect of Massive Cortisone Therapy on Measurements of Thyroid Function. The Journal of Clinical Endocrinology & Metabolism, 12, 541-553. [Google Scholar] [CrossRef] [PubMed]
[48] Terzolo, M., Osella, G., Alì, A., Borretta, G., Cesario, F., Paccotti, P. and Angeli, A. (1998) Subclinical Cushing’s Syndrome in Adrenal Incidentaloma. Clinical Endocrinology (Oxford), 48, 89-97. [Google Scholar] [CrossRef] [PubMed]
[49] Berardelli, R., Karamouzis, I., Marinazzo, E., Prats, E., Picu, A., Giordano, R., Ghigo, E. and Arvat, E. (2010) Effect of Acute and Prolonged Mineralocorticoid Receptor Blockade on Spontaneous and Stimulated Hypothalamic-Pituitary-Adrenal Axis in Humans. European Journal of Endocrinology, 162, 1067-1074. [Google Scholar] [CrossRef
[50] Deutschbein, T., Reimondo, G., Di Dalmazi, G., Bancos, I., Patrova, J., Vassiliadi, D.A., Nekić, A.B., et al. (2022) Age-Dependent and Sex-Dependent Disparity in Mortality in Pa-tients with Adrenal Incidentalomas and Autonomous Cortisol Secretion: An International, Retrospective, Cohort Study. The Lancet Diabetes & Endocrinology, 10, 499-508. [Google Scholar] [CrossRef
[51] Barzon, L., Fallo, F., Sonino, N. and Boscaro, M. (2002) Development of Overt Cushing’s Syndrome in Patients with Adrenal Incidentaloma. European Journal of Endocrinology, 146, 61-66. [Google Scholar] [CrossRef] [PubMed]